Abstract
Quantification of local similarity between protein 3D structures is a promising tool in computer-aided drug design and prediction of biological function. Over the last ten years, several computational methods were proposed, mostly based on geometrical comparisons. This review summarizes the recent literature and gives an overview of available programs. A particular interest is given to the underlying methodologies. Our analysis points out strengths and weaknesses of the various approaches. If all described methods work relatively well when two binding sites obviously resemble each other, scoring potential solutions remains a difficult issue, especially if the similarity is low. The other challenging question is the protein flexibility, which is indeed difficult to evaluate from a static representation. Last, most of recently developed techniques are fast and can be applied to large amounts of data. Examples were carefully chosen to illustrate the wide applicability domain of the most popular methods: detection of common structural motifs, identification of secondary targets for a drug-like compound, comparison of binding sites across a functional family, comparison of homology models, database screening.
Keywords: Local similarity, three-dimensional comparison, protein structure, binding site, molecular shape, drug design, function assignment
Current Computer-Aided Drug Design
Title: How to Measure the Similarity Between Protein Ligand-Binding Sites?
Volume: 4 Issue: 3
Author(s): Esther Kellenberger, Claire Schalon and Didier Rognan
Affiliation:
Keywords: Local similarity, three-dimensional comparison, protein structure, binding site, molecular shape, drug design, function assignment
Abstract: Quantification of local similarity between protein 3D structures is a promising tool in computer-aided drug design and prediction of biological function. Over the last ten years, several computational methods were proposed, mostly based on geometrical comparisons. This review summarizes the recent literature and gives an overview of available programs. A particular interest is given to the underlying methodologies. Our analysis points out strengths and weaknesses of the various approaches. If all described methods work relatively well when two binding sites obviously resemble each other, scoring potential solutions remains a difficult issue, especially if the similarity is low. The other challenging question is the protein flexibility, which is indeed difficult to evaluate from a static representation. Last, most of recently developed techniques are fast and can be applied to large amounts of data. Examples were carefully chosen to illustrate the wide applicability domain of the most popular methods: detection of common structural motifs, identification of secondary targets for a drug-like compound, comparison of binding sites across a functional family, comparison of homology models, database screening.
Export Options
About this article
Cite this article as:
Kellenberger Esther, Schalon Claire and Rognan Didier, How to Measure the Similarity Between Protein Ligand-Binding Sites?, Current Computer-Aided Drug Design 2008; 4 (3) . https://dx.doi.org/10.2174/157340908785747401
DOI https://dx.doi.org/10.2174/157340908785747401 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Therapeutic Strategies To Prevent Neurodegeneration And Promote Regeneration In Multiple Sclerosis
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Microwave and Conventional Method Assisted Synthesis of 2-(substituted) -3-(4-methoxybenzyl) Thiazolidin-4-ones Using ZrOCl2·8H2O as a Catalyst
Current Microwave Chemistry Drugs for AIDS
Mini-Reviews in Medicinal Chemistry Proteomics of Human Pulmonary Surfactant Proteins
Current Proteomics 6,7-Dihydroxyisoindolin-1-one and 7,8-Dihydroxy-3,4-Dihydroisoquinolin- 1(2H)-one Based HIV-1 Integrase Inhibitors
Current Topics in Medicinal Chemistry Alveolar Capillary Dysplasia: A Lethal Developmental Lung Malformation
Current Respiratory Medicine Reviews Subtype Selectivity in Phosphodiesterase 4 (PDE4): A Bottleneck in Rational Drug Design
Current Pharmaceutical Design The Role of the Calcium-Sensing Receptor in Bone Biology and Pathophysiology
Current Pharmaceutical Biotechnology Role of CD73 in Disease: Promising Prognostic Indicator and Therapeutic Target
Current Medicinal Chemistry Agents for the Inhibition of Cholesteryl Ester Transfer Protein (CETP) and Prospects for the Future Treatment of Atherosclerosis
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Aptamers: Selection, Modification and Application to Nervous System Diseases
Current Medicinal Chemistry Plasticity of Neuroendocrine-Immune Interactions During Ontogeny: Role of Perinatal Programming in Pathogenesis of Inflammation and Stress- Related Diseases in Adults
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Meet Our Editorial Board Member (Materials Science)
Current Chinese Science Myositis Associated with the Anti-COVID-19 Covishield Vaccine
Current Respiratory Medicine Reviews Airway Smooth Muscle Responsiveness: The Origin of Airway Hyperresponsiveness in Asthma?
Current Respiratory Medicine Reviews Syk: A Novel Target for Treatment of Inflammation in Lung Disease
Inflammation & Allergy - Drug Targets (Discontinued) Drug Design Targeting the Main Protease, the Achilles Heel of Coronaviruses
Current Pharmaceutical Design Natural and Synthetic Retinoids: Structural Bases and Biological Effects of Potential Clinical Relevance for the Prevention and Treatment of Infection-Driven Tumors
Anti-Infective Agents in Medicinal Chemistry Discovery of Potent, Non-Steroidal and Highly Selective Glucocorticoid Receptor Antagonists with Anti-Obesity Activity
Letters in Drug Design & Discovery Diagnostic Value of Chest CT in Coronavirus Disease 2019 (COVID-19)
Current Medical Imaging